Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Rising Beauty Consciousness
2.5.2. Growing Preference Towards Non-Invasive Procedures
2.5.3. Rapid Technological Advancements To Promote Market Growth
2.5.4. Rapidly Changing Lifestyles Leading To Obesity

3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing Demand For Aesthetic And Cosmetic Procedures
3.1.2. Rising Cases Of Obesity
3.1.3. Rapidly Booming Medical Tourism Industry
3.2. Key Restraints
3.2.1. High Cost Of Advanced Cellulite Treatment
3.2.2. Side Effects Post-Treatment
3.2.3. Lack Of Awareness

4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Technology Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Value Chain Analysis
4.7.1. Research And Development
4.7.2. Product Development
4.7.3. Marketing And Distribution
4.7.4. Post-Sales Monitoring
4.8. Key Buying Criteria
4.8.1. Cost
4.8.2. Brand Reputation
4.8.3. Usability

5. Market By Procedure
5.1. Non-Invasive
5.2. Minimally Invasive
5.3. Topical

6. Market By Type
6.1. Soft Cellulite
6.2. Hard Cellulite
6.3. Edematous Cellulite

7. Market By End-User
7.1. Hospitals
7.2. Clinics And Beauty Centers
7.3. Other End-Users

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. North America Cellulite Treatment Market Drivers
8.1.3. North America Cellulite Treatment Market Challenges
8.1.4. North America Cellulite Treatment Market Regulatory Framework
8.1.5. Key Players In North America Cellulite Treatment Market
8.1.6. Country Analysis
8.1.6.1. United States
8.1.6.1.1. United States Cellulite Treatment Market Size & Opportunities
8.1.6.2. Canada
8.1.6.2.1. Canada Cellulite Treatment Market Size & Opportunities

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Expansions & Divestitures
9.2. Company Profiles
9.2.1. Abbvie Inc
9.2.1.1. Company Overview
9.2.1.2. Financial Analysis
9.2.1.3. Products / Services List
9.2.1.4. Strengths & Challenges
9.2.2. Alma Lasers
9.2.2.1. Company Overview
9.2.2.2. Products / Services List
9.2.3. Bausch Health Companies Inc.
9.2.3.1. Company Overview
9.2.3.2. Financial Analysis
9.2.3.3. Products / Services List
9.2.3.4. Strengths & Challenges
9.2.4. Candela Corporation
9.2.4.1. Company Overview
9.2.4.2. Products / Services List
9.2.4.3. Strengths & Challenges
9.2.5. Cutera Inc
9.2.5.1. Company Overview
9.2.5.2. Financial Analysis
9.2.5.3. Products / Services List
9.2.5.4. Strengths & Challenges
9.2.6. Cynosure Llc
9.2.6.1. Company Overview
9.2.6.2. Products / Services List
9.2.6.3. Strengths & Challenges
9.2.7. Endo International Plc
9.2.7.1. Company Overview
9.2.7.2. Financial Analysis
9.2.7.3. Products / Services List
9.2.7.4. Strengths & Challenges
9.2.8. Galderma Sa
9.2.8.1. Company Overview
9.2.8.2. Products / Services List
9.2.8.3. Strengths & Challenges
9.2.9. Inceler Medikal Co Ltd
9.2.9.1. Company Overview
9.2.9.2. Products / Services List
9.2.9.3. Strengths & Challenges
9.2.10. Johnson & Johnson
9.2.10.1. Company Overview
9.2.10.2. Financial Analysis
9.2.10.3. Products / Services List
9.2.10.4. Strengths & Challenges
9.2.11. Merz Pharma Gmbh & Co Kgaa
9.2.11.1. Company Overview
9.2.11.2. Products / Services List
9.2.11.3. Strengths & Challenges
9.2.12. Nubway Co Ltd
9.2.12.1. Company Overview
9.2.12.2. Products / Services List
9.2.13. Sientra Inc
9.2.13.1. Company Overview
9.2.13.2. Financial Analysis
9.2.13.3. Products / Services List
9.2.13.4. Strengths & Challenges
9.2.14. Sinclair Pharma
9.2.14.1. Company Overview
9.2.14.2. Products / Services List
9.2.15. Zimmer Medizinsysteme
9.2.15.1. Company Overview
9.2.15.2. Products / Services List
9.2.15.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Technology Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Value Chain Analysis
Figure 7: Key Buying Criteria
Figure 8: North America Cellulite Treatment Market, Growth Potential, By Procedure, In 2022
Figure 9: North America Cellulite Treatment Market, By Non-Invasive, 2023-2032 (In $ Million)
Figure 10: North America Cellulite Treatment Market, By Minimally Invasive, 2023-2032 (In $ Million)
Figure 11: North America Cellulite Treatment Market, By Topical, 2023-2032 (In $ Million)
Figure 12: North America Cellulite Treatment Market, Growth Potential, By Type, In 2022
Figure 13: North America Cellulite Treatment Market, By Soft Cellulite, 2023-2032 (In $ Million)
Figure 14: North America Cellulite Treatment Market, By Hard Cellulite, 2023-2032 (In $ Million)
Figure 15: North America Cellulite Treatment Market, By Edematous Cellulite, 2023-2032 (In $ Million)
Figure 16: North America Cellulite Treatment Market, Growth Potential, By End-User, In 2022
Figure 17: North America Cellulite Treatment Market, By Hospitals, 2023-2032 (In $ Million)
Figure 18: North America Cellulite Treatment Market, By Clinics And Beauty Centers, 2023-2032 (In $ Million)
Figure 19: North America Cellulite Treatment Market, By Other End-Users, 2023-2032 (In $ Million)
Figure 20: North America Cellulite Treatment Market, Country Outlook, 2022 & 2032 (In %)
Figure 21: United States Cellulite Treatment Market, 2023-2032 (In $ Million)
Figure 22: Canada Cellulite Treatment Market, 2023-2032 (In $ Million)
Figure 23: Abbvie Inc Company Profit 2017 - 2021 ($ Billion)
Figure 24: Abbvie Inc Company Revenue – By Geography, Fy 2021-22 (In %)
Figure 25: Abbvie Inc Company Revenue – By Segment, 2021 (In %)
Figure 26: Bausch Health Companies Inc Company Profit 2017 - 2021 ($ Billion)
Figure 27: Bausch Health Companies Inc Company Revenue – By Geography, Fy 2021-22 (In %)
Figure 28: Bausch Health Companies Inc Company Revenue – By Segment, 2021 (In %)
Figure 29: Cutera Inc Company Profit 2017 - 2021 ($ Million)
Figure 30: Cutera Inc Company Revenue – By Geography, Fy 2021-22 (In %)
Figure 31: Cutera Inc Company Revenue – By Segment, 2021 (In %)
Figure 32: Endo International Plc Company Profit 2018 - 2021 ($ Million)
Figure 33: Endo International Plc Company Revenue – By Geography, Fy 2021-22 (In %)
Figure 34: Endo International Plc Company Revenue – By Segment, 2021 (In %)
Figure 35: Johnson & Johnson Company Profit 2017 - 2021 ($ Billion)
Figure 36: Johnson & Johnson Company Revenue – By Segment, 2021 (In %)
Figure 37: Johnson & Johnson Company Revenue 2017 - 2021 ($ Billion)
Figure 38: Johnson & Johnson Company Revenue – By Geography, Fy 2021-22 (In %)
Figure 39: Sientra Inc Company Profit 2017 - 2021 ($ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES